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The Hepatitis B core antigen (HBcAg) has been proposed to be an ideal candidate for use 
as an adjuvant due to its immunogenicity, and tolerance to manipulations such as insertions of 
epitopes  or  covalent  attachment  of  ligands.  HBcAg is  a  complex  macromolecule  containing 
protein and nucleic acid.  We investigated the effect of the removal and reconstitution of nucleic 
acids upon its structure. It’s been shown that the RNA content of hepadnavirus core antigens can 
be reduced significantly,  but not be completely removed.  Following removal  of some of the 
RNA, antigens retain the ability to bind added nucleic acids, in particular, "immune-enhancing" 
synthetic oligonucleotides without affecting the structure of antigen or disrupting its ability to 
spontaneously self-assemble into core particles. The removal and addition of nucleic acids was 
2successfully applied to an altered woodchuck core antigen, with a nucleic acid-based malaria 
epitope addition, giving rise to a potential vaccine adjuvant platform for malaria. 
3Chapter 1: Introduction and Background
Hepatitis
Hepatitis  is  a  cyto-specific  archaic  disease  which  affects  liver  cells,  resulting  in 
inflammation, hepatocellular damage, hepatocellular carcinoma (HCC) and cirrhosis of the liver. 
It is caused by five distinct viruses, Hepatitis A, B, C, D, and E (16).  Though this group of 
viruses  all  affect  the  liver,  they  all  belong  to  independent  families,  and  have  very  little  in 
common.  They  can  be  found  all  over  the  world,  with  a  higher  prevalence  in  the  Eastern 
hemisphere and third-world countries. The mode of transmission varies from fecal-oral means, to 
exposure  to  infected  blood,  and  unprotected  sex  with  an  infected  individual.  Specifically, 
Hepatitis A and Hepatitis E are capable of being transmitted via the fecal-oral pathway, while 
Hepatitis  B,  C  and  D  are  blood  borne  and  can  be  transmitted  through  sex  with  infected 
individuals (16).
HBV Epidemiology and Pathogenicity 
Of these five viruses, Hepatitis B (HBV) can arguably be described as the virus which 
impacts the human population the most. Along with Hepatitis C, HBV is responsible for 80% of 
HCC cases in the world, which is the fifth most common cancer, and the third leading cause of 
all cancer deaths (24).  It is estimated that annually, 500,000 to 1,000,000 new cases of HCC are 
documented (6).
 As mentioned previously, the Hepatitis B virus can be found throughout the world. It is 
most endemic throughout Africa, Central and South East Asia, and the Amazon Basin (4) (Figure 
1).  Contraction of the virus only occurs through contact with infected blood or bodily fluids, 
4Figure 1: Geographic distribution of prevalence of the Hepatitis B Virus. Adapted from 
Cooke (3)
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6such  as  semen,  and  thus  can  occur  through  vertical  (at  the  time  of  birth,  not  in  utero)  or 
horizontal transmission (4). Vertical infection is more common in areas with higher prevalence. 
Horizontal  infection,  through  contact  with  infected  bodily  fluids,  is  the  prevalent  mode  of 
transmission in areas where the virus in less common. 
Globally there are eight genetically distinct genotypes of Hepatitis B (11). Designated 
HBV/A –  H.  Each  of  these  subtypes  dominates  various  geographical  areas,  and  very  often 
overlap within these areas (Figure 2) (11). As a criterion for genotype distinction, all genotypes 
must have at least an 8% divergence from one another (11). The overlapping and distribution of 
the subtypes seen in Figure 2 are thought to be a consequence of human migration (11). Though 
there isn’t much evidence to suggest that one subtype is more virulent than another, there have 
been some evidence that suggests disease consequences and therapy response may be related to 
the genotype involved (11).
Once infected, depending on an infected individual’s  immune defense, certain clinical 
sequelae  may  arise.  An  individual  may  experience  acute  hepatitis  that  may  or  may  not  be 
accompanied with symptoms. Asymptomatic acute hepatitis can occur if an appropriate immune 
response is initiated upon infection while the number of hepatocytes infected is still  low (7). 
Two-thirds of individuals with acute hepatitis are asymptomatic. The other one-third experiences 
clinical  symptoms of the disease (11).  In these individuals  an immune response is mounted, 
however,  the amount  of hepatocytes  infected is great enough that their  destruction results  in 
inflammation  of  the  liver  (7).  Individuals  in  whom this  occurs  can  experience  a  barrage  of 
symptoms such as fever, fatigue, nausea, jaundice and liver failure (11).
7Figure 2:  Geographical distribution of the two main dominant genotypes of HBV for each 
region. Adapted from Kramvis et al. (2)
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9Three  to  eight  percent  of  all  infected  individuals  will  experience  chronic  hepatitis 
infection, when their immune system is unable to clear the virus. The result is a complicated 
relationship between host and virus, initiating a “seesaw” of dominance, where in one instance 
the immune system keeps the virus at bay and another instance viral replication will dominate 
(7). A consequence of chronic hepatitis infection is persistent clinical symptoms. One-third of 
chronically infected individuals will develop HCC, cirrhosis, or end-stage liver disease (11).
Structure, Life cycle, and Serology
The structure of the Hepatitis B Virus has been well studied and characterized. It is a 
unique DNA virus with similarities that are reminiscent of retroviruses. There are three different 
structures  that can be identified, the Dane Particle and two other smaller structures (Figure 3). 
These smaller structures are non-infectious and are devoid of any genomic information. They are 
spherical structures that are 20 nm in diameter and comprised of viral proteins and lipids from 
the host as well as 22 nm wide filaments of variable length. These are referred to as  the Hepatitis 
B Surface antigen. The Dane particle is the virus (HBV) in its infectious form. It is a 42 nm 
spherical  particle,  consisting  of  an  inner  and  outer  shell.  The  outer  shell  is  made  of  non-
infectious lipid, recruited from the host, and three lipoproteins containing Hepatitis B Surface 
Antigen (HBsAg), known as large pre-S1, middle pre-S2, and major S protein. The inner shell is 
made up of another antigen,  known as the Hepatitis  B Core antigen (HBcAg). The genomic 
information of the virus which is a 3.2 kb partially double stranded DNA, and viral polymerase, 
can be found inside the capsid formed by the core antigen (Figure 4) (7).
10
Figure 3: HBV Particles. A)  HBV virus Dane particle, 40 nm in diameter. B) Spherical 
particles found in serum of approximately 20 nm in diameter. C) Filamentous 
particles found in serum which can be up to 200 nm in length. Adapted from Hunt 
et al (30).
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Figure 4: Structure and Gene Map of HBV genome. A) Structure of the partially double 
stranded relaxed-circular DNA (RC-DNA).  B) Gene map of the Hepatitis B 
Virus 3.2kb genome. S- Surface Antigen, C: Core and E Antigen, X: X-antigen, 
P: P-protein or Polymerase Adapted from Beck et al (1)
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The 3.2kb partially-double stranded DNA has the ability to code for several different 
proteins from four different ORFs designated as S, C, P, and X. These open read frames give rise 
to the Surface antigen, Core antigen, E antigen, Polymerase, and X antigen. The pre-S1 and pre-
S2 proteins and surface antigen are derived from ORF S, while the Core and E antigen are made 
from the ORF C. ORF C has two different, in frame, start codons, known as the pre-core and 
core regions. If translation is initiated at the pre-core start codon, the E antigen is made while the 
core antigen is made with initiation at the core-region. The peptide produced from the pre-core 
region  is  further  modified  by  the  endoplasmic  reticulum  to  produce  the  E  antigen,  whose 
function is still being studied. The P and X ORFs produce the polymerase or P-protein and X 
antigen, respectively (11).
During infection, the Dane Particle first enters hepatocytes through an interaction with a 
receptor on the cell, not yet identified in humans (7). This interaction most likely occurs through 
the pre-S1 and pre-S2 proteins (7). Viral DNA then enters the cell via an unknown mechanism, 
where  the  viral  polymerase,  covalently  attached  to  the  DNA,  converts  the  partially  double-
stranded  DNA  into  fully  double  stranded  DNA.  In  doing  so  it  converts  the  DNA  from  a 
circularized  yet  open  state,  referred  to  as  relaxed-circular  DNA (RC-DNA),  into  covalently 
closed circular DNA or cccDNA (1).  This reaction also involves cellular enzymes to ligate the 
DNA.  The P-protein achieves the conversion from RC-DNA to cccDNA via its DNA dependent 
DNA synthesis activity (1). Once inside hepatocytes, the viral DNA can begin replication. Host-
derived RNA polymerase II is used to transcribe both genomic and subgenomic RNA products 
from the cccDNA. mRNA transcribed from the DNA gives rise to all of the HBV proteins.  Pre-
genomic RNA along with the polymerase is encapsulated into new virions. Once packaged the 
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polymerase reverse transcribes the RNA into the RC-DNA state via its RNA dependent DNA 
synthesis or reverse transcriptase activity. At this point, virions can play two different roles. It 
can either perpetuate infection by amplifying the amount of cccDNA or it can be released by the 
cell to, in turn, infect other cells.
A distinct serological pattern can be seen in individuals upon infection. After detection of 
HBV DNA, the first markers to be identified in the serum are HBsAg and HBeAg. The body is 
able  to  produce  antibodies  against  these  viral  markers  in  the  form  of  IgM  and  IgG 
immunoglobulins, (11). The first antibody to be produced is an IgM derived anti-core antigen, 
which is present until replaced by IgG derived anti-core antigen (11). Anti-HBeAg and anti-
HBsAg antibodies are also produced (11). Anti-HBsAg antibody can be detected towards the end 
of an infection, and anti-HBeAg antibody can be detected once the virus has been cleared (11). 
However, unlike anti-HBeAg antibody, anti-HBcAg and anti-HBsAg antibodies remain within 
previously infected hosts throughout their lives (11). This persistence of anti-HBcAg is the basis 
for  screening  blood  and  blood  products  for  evidence  of  previous  viral  infection,  while  the 
protective effect of the anti-HBsAg is the basis for the Hepatitis B Vaccine, which uses purified 
recombinant surface antigen to induce an immune response towards the virus (11). 
Other Viruses in the hepadnaviridae family
Beyond the Hepatitis B virus that infects human, other hepadnaviruses exist. Currently, 
there are related Hepatitis B viruses that can infect woodchucks, pekin ducks, ground squirrels, 
woolly monkeys and herons, with the possibility of more yet to be discovered (23). From those 
listed, the hepatitis B viruses that infects woodchucks and ducks have been the two, outside of 
the human virus, most studied. Though the viruses that infect the woodchuck and  duck are in 
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different  genera,  Orthohepadnavirus  and  Avihepadnavirus,  respectively,  both  are  currently 
accepted models for hepatitis B infection.
 The woodchuck hepatitis B virus (WHBV) is structurally and mechanistically similar to 
human HBV. Like human HBV, non-infectious 22 nm filaments and spherical particles of the 
same composition can be found in the serum of the infected (23).  Infectious particles are 42 nm 
to 45 nm in diameter and are structurally identical to human HBV. It contains an outer shell 
composed  of  Hepatitis  B surface  antigen  (WHsAg) with  an  inner-core  capsid  made  of  core 
antigen (WHcAg) that houses the virus’s genome and polymerase (23). 
Like the WHBV, when compared to the HBV, the duck hepatitis B virus, (DHBV), also 
shows a high degree of similarity (9). The infectious virion ranges from 40 nm to 45 nm in 
diameter. Like other genera and family members it has an outer core composed of host-derived 
lipids  and  surface  antigens,  and  an  inner  core  that,  again,  houses  the  viral  genome  and 
polymerase  (9).  Non-infectious  material  can  also  be  detected  in  the  serum  during  DHBV 
infection. However, unlike those found in the serum of the two aforementioned viruses, the non-
infectious materials found in the DHBV are larger, non-filamentous, spherical particles ranging 
in size from 30 nm to 60 nm in diameter (9). These particles are very similar in appearance to 
infectious particles, due to their size, making it hard to distinguish between the two (9). 
Hepatitis B Core-antigen
The  Hepatitis  B  Core-antigen,  also  referred  to  as  HBcAg,  is  a  highly  immunogenic 
protein (26). It is produced from the HBV core protein gene, which produces both the E-antigen 
and core antigen,  depending on which initiation  site translation  begins.  Translation from the 
second initiation site produces the 22 kilodalton core antigen (28). Both the woodchuck and duck 
HBV virus  produce  very  similar  core  antigen  proteins.  The  duck  core  antigen,  however,  is 
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slightly larger and is 30 kilodaltons (28). The core antigen can be produced by recombinant DNA 
methods, using  various  systems,  including  Escherichia  coli,  while  reserving  the  same 
characteristics seen during normal viral replication (26).
The  core  protein  found  in  human  HBV  consists  of  183  amino  acids  and  has  two 
conserved functional domains (Figure 5). The nucleic-acid binding domain (amino acid residues 
150-183)  is  located  in  the  C-terminus  and is  rich  with  arginine  residues.  This  clustering  of 
positively charged residues allows the core protein to bind the genomic RNA intermediate of the 
virus (12). The assembly domain, amino acid residues 1-149, is responsible for capsid formation 
of the inner nucleocapsid found in HBV.  The core protein secondary structure primarily consists 
of  two extended  α-helices.  HBcAg monomers  form dimers  via  two intermolecular  disulfide 
bonds with another monomer. (15). Specifically, the disulfide bonds are produced by cysteine 
residues 48 and 61, which bond to identical residues (Cys 48 to Cys 48 and Cys 61 to Cys 61) 
giving rise to dimerization (15). In addition, Cys-183 forms an additional disulfide bonds with a 
Cys-183 residue of a different monomer. and Cys-61 can form various disulfide bounds with 
other  Cysteines  (13,  25,  27). Cys-48  can  typically  be  found  either  un-bonded  with  a  free 
sulfhydryl-group or participating in a disulfide bond,  but Cys 61 is always bonded (13,15, 25, 
27).   The result of this disufide bonding pattern is a highly cross-linked capsid structure.
The dimers are formed spontaneously and  arrange into the 180-240 subunit nucleocapsid 
both , also known as Capsid-like particles, or CLPs, in vivo and in vitro (26). Dimerization of the 
HBcAg  monomers  results  in  the  display  of  the  α-helices  as  spikes  on  the  surfaces  of  the 
nucleocapsid. This 28-36 nm icosahedral structure can have either a triangulation number of 3 
(180 subunits) or a triangulation number of 4 (240 subunits) (26, 27, 28). When produced in a 
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bacterial  system, instead of the genomic viral  RNA intermediate,  the nucleocapsid envelopes 
small host-derived bacterial RNAs, which have not been well characterized.  
The core  antigen can also be produced in a bacterial  system, without its  nucleic-acid 
binding domain. This form of core antigen is referred to as truncated core antigen (Figure 5). The 
truncated core antigen loses the ability to bind RNA, but still retains the ability to dimerize and 
form icosahedral capsid particles. Figure 5 A-C also shows some of the fundamental properties 
of the HBcAg and truncated HBcAg, including molecular weight, isoelectric point, and molar 
extinction coefficient.   Of particular  note is  that  HBcAg is highly basic,  while  the truncated 
HBcAg is acidic.
Adjuvant potential of HBcAg
As mentioned previously, core antigen is highly immunogenic.  All infected individuals 
produce high titers of anti-HBcAg.  Although the reasons for this are not completely known, one 
reason may be the presence of multiple copies of the B-cell epitopes of the antigen. The major B-
cell  epitope  of  HBcAg  is  located  at  the  tip  of  the  spikes  present  on  the  surface  of  the 
nucleocapsid, within residues 75-83 (26, 27).  Because each nucleocapsid has hundreds of these 
spikes,  there  are  many such epitopes  displayed  on its  surface.   Moreover,  HBcAg has been 
shown to convey high immunogenicity on epitopes inserted into its structure.
Due to this trait, it has been of interest to use the core-antigen as an platform for various 
epitopes  to try to induce protective antibodies and thus immunity to various disease causing 
organisms. However, many individuals may have anti-HBcAg antibodies, especially in highly 
endemic areas and this may compromise the ability of HBcAg to function as an effective carrier, 
as it  would be immediately recognized as only HBcAg and attacked by the immune system. 
Moreover, the presence of anti-HBcAg is used to screen out potentially infected blood. 
19
Figure 5: Amino Acid sequence of the HBV Core antigens
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  A) 
Human Core 
1  MDIDPYKEFG ATVELLSFLP SDFFPSVRDL LDTASALYRE ALESPEHCSP 
      51  HHTALRQAIL CWGELMTLAT WVGVNELDPG SRDLVVSYVN TNMGLKFRQL 
     101  LWFHISCLTF GRETVIEYLV SFGVWIRTPP AYRPPNAPIL STLPETTVVR 
     151  RRGRSPRRRT PSPRRRRSQS PRRRRSQSRE SQC*
Molecular weight =   21101.92     Residues =    183
Isoelectric point = 10.69
Extinction coefficient =  29280
                Assembly domain
               Nucleic acid binding domain
 Truncated  Human Core 
        1  MDIDPYKEFG ATVELLSFLP SDFFPSVRDL LDTASALYRE ALESPEHCSP 
      51  HHTALRQAIL CWGELMTLAT WVGVNELDPG SRDLVVSYVN TNMGLKFRQL 
     101  LWFHISCLTF GRETVIEYLV SFGVWIRTPP AYRPPNAPIL STLPETTVV* 
Molecular weight =   16830.16     Residues =    149
Isoelectric point =  4.80
Extinction coefficient =  29250
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B)
Woodchuck Core
        1  MDIDPYKEFG SSYQLLNFLP LDFFPDLNAL VDTATALYEE ELTGREHCSP 
      51  HHTAIRQALV CWDELTKLIA WMSSNITSEQ VRTIIVNHVN DTWGLKVRQS 
     101  LWFHLSCLTF GQHTVQEFLV SFGVWIRTPA PYRPPNAPIL STLPEHTVIR 
     151  RRGGARASRS PRRRTPSPRR RRSQSPRRRR SQSPSANC
Molecular weight =   21693.46     Residues =    188
Isoelectric point = 10.88
Extinction coefficient =  33690
                Assembly domain
               Nucleic acid binding domain
Truncated Woodchuck Core
        1  MDIDPYKEFG SSYQLLNFLP LDFFPDLNAL VDTATALYEE ELTGREHCSP 
      51  HHTAIRQALV CWDELTKLIA WMSSNITSEQ VRTIIVNHVN DTWGLKVRQS 
     101  LWFHLSCLTF GQHTVQEFLV SFGVWIRTPA PYRPPNAPIL STLPEHTVI 
Molecular weight =   17266.57     Residues =    149
Average Residue Weight = 115.110     Charged =   -6
Isoelectric point =  5.51
Extinction coefficient =  33660
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C)
Duck Core
        1  MDINASRALA NVYDLPDDFF PKIDDLVRDA KDALEPYWRS DSIKKHVLIA 
      51  THFVDLIEDF WQTTQGMHEI AEALRAVIPP TTTPVPAGYL IQHEEAEEIP 
     101  LGDLFKHQEE RIVSFQPDYP ITARIHAHLK AYAKINEESL DRARRLLWWH 
     151  YNCLLWGEAN VTNYISRLRT WLSTPERYRG RDAPTIEAIT RPIQVAQGGR 
     201  KTSSGTRKPR GLEPRRRKVK TTVVYGRRRS KSRDRRAPSP QRAGSPLPRS 
     251  SSSHRRSPSP RK*
Molecular weight =   30247.00     Residues =    262
Isoelectric point = 10.81
Extinction coefficient =  45690
                Assembly domain
               Nucleic acid binding domain
Truncated Duck Core
        1  MDINASRALA NVYDLPDDFF PKIDDLVRDA KDALEPYWRS DSIKKHVLIA 
      51  THFVDLIEDF WQTTQGMHEI AEALRAVIPP TTTPVPAGYL IQHEEAEEIP 
     101  LGDLFKHQEE RIVSFQPDYP ITARIHAHLK AYAKINEESL DRARRLLWWH 
     151  YNCLLWGEAN VTNYISRLRT WLSTPERYRG RDAPTIEAIT RPIQVAQGGR 
     201  KTSSGT
Molecular weight =   23747.60     Residues =    206
Isoelectric point =  6.10
Extinction coefficient =  44410
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D)
Malaria Construct (FLW Mal 78 UTC)
        1  MDIDPYKEFG SSYQLLNFLP LDFFPDLNAL VDTATALYEE ELTGREHCSP 
      51  HHTAIRQALV CWDELTKLIA WMSSNITSGI LNANPNVDPN ANPNANPNAN 
     101  PLEQVRTIIV NHVNDTWGLK VRQSLWFHLS CLTFGQHTVQ EFLVSFGVWI 
     151  RTPAPYRPPN APILSTLPEH TVIRRRGGAR ASRSPRRGTP SPRRRRSQSP 
     201  RRRRSQSPSA NCDIEYLNKI QNSLSTEWSP CSVT*
Molecular weight =   26511.64     Residues =    234
Isoelectric point =  9.00
Extinction coefficient =  40690
                Assembly domain
               Nucleic acid binding domain         
              Malaria epitope
               Universal T cell epitope
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Therefore, the immunization of large numbers of individuals with HBcAg would compromise 
this test.  Therefore, researchers have focused on the core-antigen of related hepadnavirus, such 
as those from duck and woodchuck HBcAg as possible carriers instead of HBcAg.
Furthermore,  the  core-antigen  has  great  potential  as  a  carrier because  it’s  easily 
manipulated. The spontaneous assembly of particles can occur in the absence of its nucleic-acid 
binding domain or without the presence of the disulfide-bonds normally found (27). Chemical 
modification of the core-antigen is also possible due to the presence of free sulfhydryl groups, 
allowing for the addition of foreign epitopes (27).
  Researchers have attempted various approaches to antigen modification, including but 
not  limited  to,  adding  immunogenic  peptide  segments,  or  epitopes,  within  the  protein itself. 
However, a drawback is that additions to the amino acid sequence aren’t always well tolerated 
and can abolish particle formation, but  successful attempts have been documented (26). Other 
attempts  have  focused  on  manipulation  of  the  bacterial  RNA content  of particles  made  by 
recombinant DNA methods. It’s known that the RNA content of the HBcAg is approximately 
20% by weight, giving rise to an  A260/A280  absorbance ratio of 1.5-1.6 due to the absorbance 
of the RNA at 260 nm (unpublished, D. Peterson).  It has been suggested that this RNA enhances 
the immunogenicity of the core particle (2). 
Unfortunately, the presence of bacterial RNA has the ability to complicate determination 
of the adjuvant potential of the core antigen, and in the case of vaccine formation, its presence 
may be undesired (2).  Therefore, it is of interest to many researchers to remove this bacterial 
RNA and produce RNA-free particles, without abolishing the nucleic-acid binding domain  (2). 
There is also a need to produce RNA-free particles in order to incorporate other specific immune 
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stimulatory  synthetic  oligonucleotides,  again  in  attempt  to  enhance  the  immunogenicity 
properties of an HBcAg carrier (5). 
The focus of this study is to clearly define the RNA content of the HBcAg's from HBV, 
WHBV, and DHBV and to create an affordable and reproducible method of removing RNA from 
particles produced in an  E. coli  system. It is of importance to determine if the removal of the 
RNA from particles affects its structural integrity in any fashion. In addition it is of interest to 
determine  whether,  upon  RNA  removal,  an  oligonucleotide  of  a  specific  sequence  can  be 
incorporated within the particle.  Ultimately,  it  is hoped this information can be to applied to 
other  antigens  such  as  the  modified woodchuck  core  antigen  containing  a  malaria  epitope 
insertion at position 78 within its loop region, currently being evaluated as a potential malaria 
vaccine  candidate  (Figure 5).  The insertion within the loop region allows presentation  of an 
amino acid repeat of NANP. This repeat corresponds to one found on the surface coat protein of 
the  circumsporozoite  life  stage of  the  major  malaria  pathogen,  Plasmodium falciparum. The 
sporozoite life stage is the stage in which the parasite initially enters human hosts. Immunity to 
the coat protein present in this stage could prevent entrance of the parasite into host cells.
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Chapter 2: Methods and Materials
Plasmid Construction
Construction of the plasmids for woodchuck, human and duck Hepatitis B Core antigen 
were all achieved by the same method.  Nucleotides 1902 through 2805, which corresponds to 
the complete full length Hepatitis B Core antigen were cut from the appropriate parent HBV 
(ayw)-PBR322 plasmid, using blunt end sites, NlaIII and HhaI sites. A HIND III linker was then 
added to the 3’ end of the fragment and the resulting fragment was ligated, in frame, into the 
ampicillin-resistant pUC18 plasmid vector using blunt-ended sites SstI and HIND III.
Protein Expression and Purification
Plasmids were  either transformed into competent TB1 or Top 10  E. coli cells via heat 
shock or electroporation, using electro-competent E. coli cells. These cells were then spread, in 
dilutions, on agar plates containing ampicillin. Select colonies were isolated for growth in a 10 
ml, ampicillin-containing medium. The cultures were then used to grow 100 ml cultures in the 
same medium previously mentioned. From the 100 ml cultures, 10 liters of the bacteria were 
grown in either TYN medium (10 g of NZ Amine, 10 g of yeast extract, 5 g of NaCl, and 5 ml of 
20% dextrose per liter) or auto-induction medium (100 g N-Z amine,  50 g yeast extract,  7 g 
sodium sulfate, 26.5 g ammonium chloride, 67 g dibasic sodium phosphate, 34 g monobasic 
potassium phosphate per 10 liters). Using the auto-induction medium, some cell cultures were 
grown in large 40 L batches, using a 40 liter yeast bacteria fermenter. 
Cell cultures were allowed to grow overnight, for at least 24 hours at 37° C before being 
harvested. Cultures were spun down, collected and broken in dilute Tris buffer (10 mM) at high 
pressure using an Avestin  Emulsiflex  operating  at  a  pressure of  15000 psi  or  greater.  Once 
broken the cell lysate was heated to 70° C and spun down at 10,000 x g for thirty minutes, and 
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the resulting supernatant was collected. An ammonium sulfate precipitation was performed at a 
concentration of 277 g per liter of supernatant. This solution was allowed to sit for 30 minutes or 
overnight. It was then spun down again at 10,000 x g for 30 minutes and the pellet was collected. 
The pellet was re-dissolved in either 25 mM sodium phosphate buffer or 10 mM Tris buffer. 
The re-suspended pellet  was applied to a  Sepharose CL4B column. Ten to fifteen ml 
fractions were collected in the same buffer used to re-dissolve the ammonium sulfate pellet. The 
absorbance of the fractions at 280 nm was determined using a spectrophotometer. The readings 
from the fractions were plotted on a graph and the location of peaks potentially containing the 
target protein was determined. Determination of protein location was accomplished through the 
use of  12.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE). Before 
being  applied  to  the  SDS-PAGE  gel,  sample  buffer  containing  the  reducing  agent, 
mercaptoethanol, and SDS was added to the samples in order to break disulfide bonds present. 
The samples were then heated in water until boiling and applied to the gels.
When the fractions containing the target proteins were confirmed, they were pooled, and 
then,  depending  on  the  purity  of  the  protein,  samples  may  have  been  subjected  to  further 
purification  methods.  The  fractions  containing  the  target  protein  were  pooled  together  and 
subjected to a second ammonium sulfate precipitation, again at the concentration of 277 g per 
liter. This sample was then spun at 10,000 x g for 30 minutes. The pellet was collected and re-
suspended using a 10mM Tris-buffer. The re-suspended pellet was dialyzed over-night against 
10mM Tris-buffer in order to remove the ammonium sulfate. The purity of the sample was then 
confirmed, again, using SDS-PAGE. 
Structural Analysis of Proteins
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The structural analyses of the proteins were carried out before and after RNase digestion 
of  the  proteins,  and  after  nucleotide  reincorporation.  Three  methods  were  used,  Circular 
dichroism (CD) spectrometry, Absorbance spectrometry, and Dynamic light scattering. In order 
to  determine  the  effect  RNA and its  removal  has  on  the  absorbance  spectrums  of  the  core 
antigens,  DHBcAg.  WHBcAg,  and  HBcAg,  their  truncated  counterparts,  and  the  Malaria 
construct were scanned, using a spectrophotometer, from wavelengths 220 nm to 300 nm.  The 
expected  absorbance  at  280  nm  was  determined  based  on  the  molar  extinction  coefficient 
calculated from the amino acid sequence.  The data was then plotted on a graph and adjusted to a 
concentration  of  1  mg/ml,  for  the  human  full  length  and  truncated  proteins  based  on  the 
calculated  absorbance  at  280 nm, in  order  to  normalize  the  data.  In  addition,  the  data  was 
normalized for the woodchuck and duck antigens to allow comparison.
In order to investigate the secondary structure of the antigens, CD spectroscopy was used, 
specifically  on  the  woodchuck,  human,  and  Malaria  construct  core  antigens.  As  previously 
stated,  this study was done before and after  RNase digestion and oligonucleotide addition in 
order to determine if any changes to the secondary structure occurred. Proteins were diluted to a 
concentration of 0.1 mg/ml  and dialyzed into a 20 mM sodium phosphate buffer in order to 
eliminate excessive light absorbance a low UV wavelengths caused by the buffer.  Proteins were 
scanned three times  from 190 nm to 160 nm and averaged.
Dynamic light scattering was used in order to investigate particle formation and the size 
of the various core antigens. The core antigens were diluted to a concentration of 0.2 mg/ml in a 
20 mM sodium phosphate buffer. A minimum of ten readings were collected and averaged to 
determine  particle  size  using  DynaPro®  Protein  Solutions  molecular  sizing  instrument  and 
software.
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RNA Isolation
RNA was extracted and isolated for characterization from wild-type human core antigen 
and human core antigen previously subjected to RNase digestion.  A modified Trizol® protocol 
was used that allowed for extraction and recovery of total RNA from the protein. The extraction 
was performed in a laminar flow hood. The RNA was extracted from 3.34 mg – 3.7 mg of the 
protein suspension, separated into 1 ml aliquots.  The supernatant was poured off and 1ml of 
Trizol® was added.  The  mixture  was gently  pippetted  up and down in order  to  disrupt  the 
protein. After a five minute incubation period, 200 µl of chloroform was added and each tube 
was shaken for 15 seconds and allowed to incubate for three minutes. The solution was spun 
down at 2° C to 8° C for 15 minutes at 12,000 x g. Afterwards, the top aqueous phases were 
removed and placed in new tubes. 500 µl of room temperature isopropyl alcohol was added to 
the  aqueous  solution  and  centrifuged  at  12,000  x  g  for  10  minutes  at  2°  C  to  8°  C.  The 
supernatant was discarded, and the pellet formed was washed with one milliliter of 75% ethanol 
and re-spun at 7,500 x g for five minutes. The resulting RNA pellet was then allowed to air dry 
before being dissolved in DEPC-treated, RNase free water.
RNA was also isolated using a phenol-chloroform extraction method.  Twenty milliliters 
of protein at a 3mg/ml concentration was combined with an equal amount of phenol. The RNA 
was precipitated using ethanol and incubated for 24 hours at -80 degrees Celsius, then collected 
by centrifugation. The pellet was re-dissolved in 5ml of DEPC treated water. 
Furthermore, in an attempt to recover RNA with very little to no protein contamination, a 
Qiagen RNeasy® kit was used.  The manufacturer's protocol for RNA cleanup was used on both 
previously extracted RNA, and HBcAg not yet subjected to an extraction protocol. 
RNA Characterization
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The spectrum of the extracted RNA was investigated. The absorbance values of the RNA 
were evaluated from 220 nm to 300 nm. Additionally the size and purity of the isolated RNA 
was investigated. A 10% polyacrylamide gel was run and the RNA was visualized using silver 
staining. The A260/A280 absorbance ratio was determined in order to quantify that RNA was 
present.
RNase Digestion of Antigens 
Establishment of the Procedure
It was of importance to first determine the minimum amount of antigen that could be 
loaded on an agarose gel and still be seen by UV fluorescence. Decreasing amounts of HBcAg in 
10mM Tris buffer, ranging from 20 µg to 0.025 µg, were run on a 1% agarose gel, containing 
ethidium bromide.  Next, a digestion time-course experiment was performed to determine the 
minimum amount of time and RNase needed for digestion to occur. Varying amounts of RNase 
A, ranging from 5 µg to 300 µg, were used for the digestion of 200 µg of HBcAg protein. The 
digestion  was  allowed  to  proceed  up  to  48  hours  at  37°  C.  Samples’  sodium  chloride 
concentration was decreased to 30 mM, and their  final  volume was increased to 30 µl using 
distilled H2O. The degree of digestion, as determined by the intensity of the ethidium bromide 
fluorescence  upon agarose  gel  electrophoresis, was  checked  every  10  minutes  for  up  to  30 
minutes. Degree of digestion was checked every 15 minutes from 30 - 120 minutes. Degree of 
digestion was checked every 30 minutes from 120 - 300 minutes. Finally, the degree of digestion 
was checked every 12 hours from 24 hours – 48 hours. 
Next,  the effect  of pH on digestion was investigated.  Five digestions  were set  up, in 
which 50 µg of RNase A was added to 20 µg of HBcAg protein. A control was established as a 
sample with the pH of the digestion left unchanged at a pH of 8, while the pHs of the remaining 
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four  digestions  were increased  to  a  pH of  9,  10,  11 or  12.  The  digestions  were  allowed to 
continue overnight at 37° C.
Digestion Kinetics
The  kinetics  of  the  RNase  A  digestion  of  the  core  antigens  was  followed  using  a 
spectrophotometer. 300 µl of distilled H2O was added to 30 µL of HBcAg at a concentration of 
13 mg/ml.  10 µL of a 10X  Coating Buffer (10 mM sodium bicarbonate and 10 mM sodium 
carbonate),  and 25 mM of the reducing agent diothiothreitol, DTT, was also added to increase 
the pH and reduce disulfide bonds, respectively. Finally 1 µg of RNase A per 100 µg of protein 
was  added  to  the  mixture.  The  absorbance  values  at  600  nm,  260  nm,  and  280  nm  was 
immediately taken and the spectrometer was then blanked against the digestion solution. The 
absorbance values were collected every three seconds for three hours at the wavelengths of 600 
nm and 260 nm.
RNase Digestion of Antigens
Larger amounts of WHBcAg and HBcAg were digested using 300 µl of antigen ranging 
from a concentration of 6 mg/ml to 13 mg/ml. The antigens were diluted to a volume of 3ml 
using water. To increase the pH and disrupt disulfide bonds, 10 µl of 10X Coating Buffer and 
50µl of 0.5 M DTT were added to the solution, respectfully.  1 µg of RNase A per 100 µg of 
antigen was added last to the solution. The digestion was allowed to proceed  for 24 hours at 37° 
C. Afterwards antigens were separated from RNase using column chromatography.  Digestion 
solutions were run on a FPLC size-exclusion column and the core antigen was recovered. If 
necessary,  proteins  were  concentrated  and  the  results  were  assayed  using  SDS-page 
electrophoresis and 1% agarose gel containing ethidium bromide.  
Addition of Oligonucleotides
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An  attempt  to  add  specific  synthetic  oligonucleotides  to  WHBcAg,  HBcAg,  and  the 
Malaria  Construct  (FLWMal78UTC)  was made.  Using  the  same  digestion  protocol  just 
mentioned, a minimum of 40 ng was added to digestion mixtures before the addition of RNase 
A. The same digestion protocol for large amounts of antigen was used. Additionally, the addition 
of  the  oligonucleotide  without  the  RNase  digestion  was  attempted,  again,  using  the  same 
protocol, and withholding RNase. The oligonucleotide used had the sequence  TCC ATG ACG 
TTC CTG ATG CT and contained a biotin molecule attached to the 5’ end. After separation on a 
FLPC column, the antigens were assayed using SDS-page electrophoresis, electrophoresis on 1% 
agarose gel containing ethidium bromide, and with an ELISA assay described below. 
A negative and positive control was used for all ELISAs performed. The negative control 
was coated with only 50 µl of a 1X coating buffer, and the positive control was coated with a 
minimum of 50 ng of the oligonucleotide in 1X coating buffer. The recovered antigens as well as 
any peaks found in the UV profile of the fractions from the column were coated into 8 different 
well of the plates in 1X coating buffer for two hours. The plate was then washed with distilled 
H2O and 100 µl of activated streptavidin-peroxidase conjugate in 2% bovine serum albumin, 
BSA, (2 µl streptavidin-peroxidase per 1 ml of BSA), was added and allowed to incubate at 
room temperature for an hour. The plates were then washed three times and 50 µl of substrate 
(TM Blue) was added to each well of the plate. The reaction was stopped using 100 µl of 1M 
phosphoric acid. 
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Chapter 3: Results
Protein Plasmid Construction and Expression
The DNA nucleotides corresponding to the core antigens and truncated core antigens for 
each species, woodchuck, human, and duck HBV, were successfully ligated,  in frame, into a 
pUC18 plasmid vector. The plasmid vector for each  were transformed into TB1 or Top10  E. 
Coli cells, either using heat-shock transformation or electroporation. Either method gave similar 
results, producing sufficient colonies on ampicillin-containing agar plates. Large batches were 
grown in  either  TYN or  auto-induction  medium,  both  of  which  effectively  induced  protein 
expression without  any noticeable  difference  in  the  amount  of  protein or  bacteria  produced. 
Following disruption by high pressure, the cell lysate was subjected to a heat-step by bringing its 
temperature to 70° C. This heat-step denatured most proteins found in the cell lysate, leaving 
only a few proteins and the desired HBcAg protein in solution following centrifugation at 15000 
x g for 30 min (Figure 6B).   The proteins were recovered by ammonium salt precipitation (45% 
saturation) and centrifugation.  When separated using a Sepharose CL4B column, the targeted 
proteins  could  be  found  in  a  second  large  peak,  following  a  “junk”  peak  with  little  to  no 
contamination (Figure 6A). A 40 liter  batch of either the TYN or Auto-Induction media was 
capable  of  producing  up  to  470  mg of  protein  which  was  sufficient  for  the  necessary 
experiments. 
Structural Analysis of Core Antigens before Digestion 
The spectrum of the full length and truncated duck, human, and woodchuck core antigens 
were  investigated  from  220  nm  and  300  nm.  When  compared  to  each  other  at  1  mg/ml 
differences  in  absorbance  maxima  could  be  seen.  The  truncated  core  antigens  all  had  an 
absorbance maximum at 280 nm, typical of most proteins. The full-length core antigens had 
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Figure 6: Graph and SDS-page gel of Column Fractions. (a) Absorbance spectrum of 
fractions collected from the CL4 column at a wavelength of 280 nm. (b) SDS-
page gel of protein extraction. (M) Molecular Weight Marker (L) Lysate (H) 
Heated Lysate (A) Ammonium Sulfate precipitation.
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Figure 7: Normalized spectra of Hepadnavirus Full Length Core Antigens vs Truncated 
Core Antigens. (A) Woodchuck Core Antigen. (B) Human Core Antigen. (C) 
Duck Core Antigen. Maximums can be seen at the 260 nm for full length core 
antigens, and 280 nm for truncated core antigens.  These spectra were normalized 
to fit on the same scale, and do not represent equal amounts of protein. 
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absorbance maximums at 260 nm rather than 280nm, suggesting the presence of nucleic acids 
(Figure 7).
The secondary structure of the full  length human and woodchuck core antigens  were 
investigated using circular dichroism spectroscopy (Figure 8). HBcAg as well as WHBcAg both 
gave  spectra  that  were  indicative  of  a  secondary structure  composed  of  alpha  helices.  Both 
antigens were then analyzed by dynamic light scattering which showed that each was present as 
macromolecular  particles.  The  average  diameter  size  was  24.4  nm was  for  the  human  core 
antigen and 18.34 nm for the woodchuck core antigen (Table 1).
RNA Isolation and Characterization
Using  the  modified  Trizol®  extraction  method,  RNA was  extracted  directly  from 
HBcAg.  Large  pellets  were  seen  and  dissolved  in  300  µl  of  DEPC-treated  water.  A  1:100 
dilution was made and the A260/280 absorbance ratio was determined to be 1.7138. Using the 
convention of 1 OD corresponding to 40 µg/ml of RNA, it was determined that 1.336 mg of 
RNA was extracted  from 3.34 mg of  protein,  or  400µg of  RNA per  1  mg of  HBcAg.  The 
spectrum of the RNA from 220 nm to 300 nm was determined and adjusted to correspond to a 1 
mg/ml concentration (Figure 9). The RNA had an absorption maximum at 260 nm.  RNA was 
also isolated from HBcAg previously digested with RNase A using the same protocol in order to 
investigate  its  RNA content  after  digestion.  It  was  determined  that  569.6  µg  of  RNA was 
extracted from 3.7 mg of protein, or 153.94 µg or RNA per 1 mg of digested HBcAg.  The RNA 
extracted  had  an  A260/280  absorbance  ratio  of  1.997,  indicating  little  contamination  with 
protein.
RNA was also extracted using a phenol-chloroform procedure. The phenol-chloroform 
extraction produced a substantial pellet that did not go completely into solution when re-
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Figure 8: Circular Dichroism Spectra (A) Woodchuck Core Antigen (B) Human Core 
Antigen. Spectra are indicative of proteins comprised of alpha helices.
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Table 1. Average diameter size of Hepadnavirus Core particles as determined by dynamic 
light scattering.
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Hepadnavirus Wild-Type Digested Oligonucleotide 
Added
Woodchuck 18.3 nm 33.9 nm 26.1 nm
Human 24.4 nm 36.4 nm 26.2 nm
Malaria Construct 21.6 nm 25.6 nm 20.5 nm
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Figure 9: Spectrum of isolated RNA from Human Core Antigen at 1mg/ml
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Figure 10: Silver-Stained  Gel  of  phenol-chloroform  RNA  extraction  of  Human  Core 
Antigen.  Tube  1  contains  material  from the  supernatant  and  Tube  2  contains 
material  from  the  pellet.  Red  Arrows  indicate  proteins  which  stained  with 
Commassie Blue and Blue arrow RNA stained by silver-staining.
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dissolved in 5 ml of DEPC-treated water. The pellet was partially re-suspended in EB buffer (10 
mM Tris-HCl pH 8, 1 mM EDTA), but still  did not completely dissolve. Both the resulting 
supernatant and un-dissolved pellet were separated on a 10% SDS-PAGE.  Components of the 
sample were visualized by silver staining (Figure 10). Both samples showed bands of protein that 
were visible with commassie blue staining. The supernatant showed a light band of RNA visible 
by silver staining. When the re-suspended pellet was separated on an identical gel, followed by 
silver-staining, a strong band of RNA was seen at the same position as the RNA present in the 
supernatant. Both RNAs were smaller than the available molecular weight markers and its size 
being less than 100 bp.
An  attempt  to  further  purify  the  RNA  was  made  using  an  Qiagen  RNeasy®  Kit, 
specifically,  the RNA clean-up protocol. The protocol was used to extract RNA directly from 
HBcAg as well as the material from the pellet and supernatant. After the RNeasy® protocol, an 
aliquot of the solution was again extracted with phenol-chloroform , to investigate whether this 
would further purify the RNA. All products were run on a polyacrylamide gel and visualized by 
silver staining.  The samples in which the RNeasy® kit and protocol were utilized showed no 
presence of RNA (data not shown).
RNase Digestion of Antigens
Using agarose gels and differing amounts of HBcAg, it was determined that a minimum 
of 20 µg would be used in RNase digestions. The RNA contained in 5 µg -10 µg of antigen and 
stained with ethidium bromide could easily be seen with the naked eye on 1% agarose gels, but 
did not show up well in photographs, while 10 µg -20 µg of antigen could both be seen and 
photographed  well.  Antigen  concentrations  of  less  than  5  µg  produced  very weak ethidium 
fluorescence, and were hard to detect with the naked eye. 
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 The time-course experiments  revealed that  1µg of  RNase per  10 µg of  antigen  was 
sufficient to digest bound RNA after 24 hours. A maximum of 2 µg of RNase per 10 µg of 
antigen was also effective for shorter digestion times, of at least 12 hours. An RNase to antigen 
ratio higher than this resulted in antigen precipitation. This phenomenon could easily be seen on 
an agarose gel because the stainable material did not move out of the sample wells. 
HBcAg precipitates from solution at pH values less than 6.5.  Therefore it was considered 
possible  that  the  digested  HBsAg  might  become  insoluble  at  even  higher  pH  values  upon 
removal of RNA.  Since RNase is active over the pH range of 6-10, the reaction pH was raised as 
described in methods and materials in order to determine if its effects would prevent the antigen 
from falling out of solution. Each reaction mixture was spun down to pellet any protein that may 
have precipitated out of solution. It was determined that an increase of pH to 9 was sufficient in 
preventing the antigens from falling out of solution. Reaction mixtures with pH values ranging 
from 10-12 also did not form a pellet. Pellet formation was only seen in the reaction mixture with 
a neutral pH.
Digestion of RNA by RNase is typically accompanied by an increase in absorbance at 
260 nm.  This increase is referred to as hyperchromicity, and the increase has been reported to be 
between 10% and 40% depending on the RNA. Therefore it was hoped that the digestion of the 
RNA in HBcAg could be followed by monitoring the hyperchromicity of the solution versus 
time.  The  kinetics  of  this  digestion  for  both  human  and  woodchuck  antigens  demonstrated 
similar patterns. When studied at a wavelength of 260 nm, the absorbance of the human antigen 
increased very slightly over time (Figure 12). Under the same parameters the absorbance of the 
woodchuck antigen also increased very slightly, however, it began to decrease during the latter 
part of the digestion (Figure 11).  When the digestion was studied at 600 nm the absorbance of 
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the  human  antigen  decreased  from its  beginning  absorbance  before  reaching  a  minima  and 
increasing  again  at  absorbance  values  near  that  of  the  original  (Figure  12).  Similarly,  the 
absorbance of the  woodchuck antigen decreased before reaching minima but instead stabilized 
near the minima (Figure 11).  Since neither RNA nor protein  absorb light at 600 nm, these small 
changes must reflect scattering of light, and the results demonstrate that this method cannot be 
used to monitor the digestion of the RNA in HBcAg.
When separated  on a  size-exclusion  column,  the digestion  mixture  was resolved  into 
three peaks of UV absorbing (280 nm) components.  When analyzed on a SDS-page gel,  the 
protein from the first peak displayed the same size as the undigested, wild-type antigen, while 
the second peak, co-migrated along with RNase. The third peak did not produce any bands upon 
commassie  blue  staining  (Figure  13).   This  last  peak  had  an  A260/280  ratio  typical  of 
ribonucleotides, and thus was the RNA digestion products. When the samples were run on an 
agarose gel,  only the first  peak produced fluorescence. The A260/280 ratio  of the recovered 
antigen was markedly decreased from their undigested antigens, 
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Figure 11: Kinetics of Digestion reaction of Woodchuck Core Antigen. (A) Kinetics at a 
wavelength of 260nm. (B) Kinetics at a wavelength of 600nm.
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Figure 12: Kinetics of Digestion reaction of Human Core Antigen. (A) Kinetics at a 
wavelength of 260nm. (B) Kinetics at a wavelength of 600nm.
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Figure 13: Separation of HBcAg using FPLC size-exclusion column filtration. (A) 
Chromatograph of UV spectrum of collected fractions. (B) SDS page-gel of 
fractions from peaks 1-3. M – Molecular weight marker. O- Original antigen, 
undigested. 1 – Separated HBcAg. 2- Separated RNase. 3- Digested RNA
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Table 2: 260/280 absorbance ratio for wild-type, digested and core antigens with the added 
oligonucleotide.
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Wild-type Digested Added 
Oligonucleotide
Woodchuck 1.53 .907 1.07
Human 1.58 1.36 1.39
Malaria Construct 1.44 1.32 1.25
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with  values  ranging  from 1.2-1.4  (Table  2).  This  decrease  could  be  seen  when  comparing 
undigested and digested antigens upon equal loading on an agarose gel (Figure 14).
When the structures were analyzed, both the human and the woodchuck produced spectra 
that deviated slightly from the untreated antigens. Maximum were still found at 260 nm, for the 
human core antigen,  yet  the amount of absorbance at this wavelength was slightly decreased 
from that of the original. The woodchuck core antigen maximum shifted from 260 nm to 280 nm 
(Figure 15). The CD spectra of the antigens after digestion remained unchanged from that of the 
undigested  antigen,  with  spectra  still  indicative  of  alpha  helices  present  (Figure  16).  After 
digestion, particle formation still  occurred, however the diameter of the particles increased in 
size.  The  average  diameter  of  HBcAg  was  36.42  nm  while  the  average  diameter  for  the 
WHBcAg was 33.91 nm. (Table 1) 
Addition of Oligonucleotide to Digested Antigen
Both  antigens,  human  and  woodchuck,  were  digested  in  the  presence  of  the 
oligonucleotide,  and  successfully  separated  by  size-exclusion  column  chromatography  and 
recovered. The recovered antigens were analyzed by an ELISA assay as previously mentioned. 
As a common convention an absorbance  value of two times that of the negative control was 
chosen to indicate a positive result. The ELISA plate reader (BIO-RAD SmartSpec 3000) which 
was used, reports data in  milli-absorbance units, and these are used here.  The negative control 
of the ELISA for the human antigen had a mean absorbance of 50, and the positive control had a 
mean absorbance of 238. The first peak, containing the antigen, had a mean absorbance of 146, 
while the remaining three peaks had absorbance values ranging from 50 – 73 (Figure 17A). The 
ELISA for the woodchuck antigen showed similar results, with a negative control absorbance 
mean value of 35 
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Figure 14: Agarose gel of WHBcAg and HBcAg before and after digestion. 1% Agarose gel 
loaded with 42 µg of antigen. Lane 1: WT HBcAg, Lane 2: Digested HBcAg, 
Lane 3: Empty, Lane 4: WT WHBcAg, Lane 5: Digested WHBcAg.
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Figure 15: Absorbance spectrum of Woodchuck and Human core antigens, before and after 
digestion.  (A) Human Core antigen (B) Woodchuck Core antigen
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Figure 16: CD spectrum of Woodchuck and Human Core antigen before and after digestion 
(A) Human Core antigen. (B) Woodchuck core antigen
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Figure 17: ELISA assay of HBcAg and WHBcAg. Assay testing for the presence of 
biotinylated DNA after digestion in the presence of the biotinylated 
Oligonucleotide. (A) Human Core Antigen (B) Woodchuck Core Antigen
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and a mean positive control value of 183. The first peak from the column had a mean value of 
113, while the remaining peaks had mean absorbance values no greater than 45 (Figure 17B). 
Woodchuck and human antigens not treated with RNase had absorbance values of 55, and 58, 
respectively.
When  analyzed  by  agarose  gel  electrophoresis,  an increase  in  fluorescence  in  both 
antigens could be seen when compared to the digested particles. This fluorescence, however, 
remained less than that of the untreated antigens (Figure 18). The presence of the protein was 
reconfirmed using an SDS-page gel and when compared to the untreated and digested antigens it 
established that the antigens were present and their size was unaffected
Structural Analysis of Antigens with Oligonucleotide addition
The absorbance  spectrums of  the  antigens  following oligonucleotide  addition  did  not 
deviate greatly from that of the digested or untreated antigens. Maximums were seen near or at 
an absorbance value of 260 nm (Figure 19). When analyzed by circular dichroism the spectrum 
revealed alpha helices still  present and intact. Dynamic light scattering showed the continued 
presence  of  HBcAg particles  after  the  addition  of  oligonucleotides.  When  compared  to  the 
digested particles,  a decrease in size in both antigens could be seen. HBcAg had an average 
particle size of 26.22 nm while WHBcAg had an average particle size of 26.09 nm (Table 1). 
Application to Malaria Construct
Structural comparisons 
The absorbance spectrum of untreated Malaria Construct followed the same pattern of 
that of the woodchuck and human core antigens, with a maximum found at an absorbance value 
of 260 nm. The circular dichroism spectrum revealed the presence of alpha helices. Untreated 
antigens of the Malaria Construct, when analyzed by dynamic light scattering, formed roughly 
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Figure 18: 1% Agarose gel of WHBcAg and HBcAg with Oligonucleotide addition. 1% 
Agarose gel of 30 µg of antigens before and after digestion and oligonucleotide 
addition. Lane: 1 WT HBcAg, Lane 2: Digested HBcAg, Lane 3: HBcAg with 
oligonucleotide, Lane 4: WT WHBcAg, Lane 5: Digested WHBcAg, Lane 6: 
WHBcAg with oligonucleotide
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Figure 19: Absorbance spectrum of Woodchuck and Human core antigens with 
oligonucleotide. Before and after digestion and oligonucleotide addition shown. 
(A) Human Core antigen (B) Woodchuck Core antigen 
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(A)
(B)
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Figure 20: CD spectrum of Woodchuck and Human Core antigen before and after Digestion 
and oligonucleotide addition (A) Human Core antigen. (B) Woodchuck core 
antigen 
73
(A)
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the same size particles as HBcAg and WHBcAg with an average particle size of 21.65 
nm (Table 1).
After  being  subjected  to  RNase  digestion,  the  Malaria  Construct  was  isolated  and 
recovered from the digestion mixture using a sizing-column. The antigen could be found in the 
first peak that came off of the column. Its absorbance spectrum and the spectrum from circular 
dichroism did not digress greatly from that of the untreated antigen (Figure 21A). Similarly when 
its CD and absorbance spectra were investigated after the addition of the oligonucleotide, there 
was very little digression when compared to both the digested and untreated antigen (Figure 
21B).  Its particle size increased to an average diameter size of 25.60 nm upon treatment with 
RNase, and like the human and core antigens, with addition of the oligonucleotide the particle 
size decreased to an average size of 20.48 nm. 
When  the  three  different  methods  of  antigen  treatment  were  analyzed  and compared 
against one another on an agarose gel, the same pattern that was observed with the woodchuck 
and human antigens was observed. The digested antigen had a decreased fluorescence from that 
of  the  untreated  antigen.  This  fluorescence  was  partially  restored  with  the  addition  of  the 
oligonucleotide,  but  still  remained  less  than  the  wild-type  antigen  (Figure  22A).  SDS-page 
confirmed that the antigens were present with their sizes unchanged (Figure 22B).  The ELISA 
confirmed addition  of the oligonucleotide  to  the antigen recovered in  the first  peak with an 
absorbance  value  of  127.5.  Other  peaks  had absorbance  values  ranging  from 37 to  33.  The 
antigen that was left in the presence of the oligonucleotide without RNase had an absorbance 
value of 104.75 (Figure 23).
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Figure 21: Absorbance and CD Spectrum of the Malaria Construct core antigen before and 
after digestion and oligonucleotide addition. (A) Absorbance Spectrum. (B) CD 
Spectrum 
76
(A)
(B)
77
Figure 22: Agarose gel of Malaria construct and SDS-page gel of all antigens before and 
after treatments. (A) 1% Agarose gel of 30µg of the Malaria Construct Core 
antigen. Lane 1: Wild-type antigen. Lane 2: Digested antigen. Lane 3: Antigen 
with added oligonucleotide.(B) SDS-page gel of all antigens before digestion 
(WT), after digestion (D), and after oligonucleotide addition (O). (M) Molecular 
weight marker. 
78
 (A)
79
(B)
80
Figure 23: Biotin ELISA assay of Malaria Construct testing for the presence of biotinylated 
DNA after digestion in the presence of the biotinylated oligonucleotide. 
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Chapter 4: Discussion
The creation of a functional adjuvant is of great importance for future vaccine creation. 
The Hepatitis B Core antigen has been proposed to be an ideal candidate for this purpose due to 
its   high immunogenicity, ease of production and its tolerance to be experimentally manipulated. 
However,  in  order  to  realize  it’s  full  potential,  its  structure  and  the  basis  for  its  high 
immunogenicity need to be well understood.  One aspect that contributes to both is the RNA 
component  of  the  antigen.  Therefore  the  objectives  of  this  study  were  to  determine  the 
composition of the particles and to elucidate the structural changes that occur in Hepatitis B core 
antigens  upon  removing  the  nucleic  acids,  with  the  goal  of  adding  back  specific,  defined 
oligonucleotides.  Our studies suggest that  the nucleic  acid content  of core antigens could be 
manipulated and such manipulation resulted in core particles  that  remained intact,  with little 
structural changes. 
Quantification of the RNA and Protein Content of HBcAg
The problem with trying to quantify the amount of RNA and protein in HBcAg arises 
from the difficulty in determining the amount of HBcAg being used.  Without knowing the molar 
extinction coefficient at a defined wavelength (such as 280 nm) no calculation is possible.  One 
could weigh the sample following extensive dialysis and drying, but this would require using a 
very large amount to obtain accurate weights.  However, the spectral properties of the isolated 
RNA along with the predicted spectral properties of HBcAg protein can be used to establish a 
quantitative measure of RNA and protein.
The truncated HBcAg contains only the protein (Figure 5) and no bound RNA.  Its molar 
extinction coefficient at 280 nm is readily calculated from the amino acid sequence (Figure 5). 
Because the full length HBcAg and the truncated HBcAg have identical amino acid sequences 
83
except for the lack of the arginine rich nucleic acid binding domain in the case of the truncated 
HBcAg,  and  because  they  do  not  differ  at  all  in  aromatic  residues  which  contribute  to  the 
absorbance  at  280  nm,  their  absorbance  values  at  280  and  260  nm should  be  the  same  at 
equimolar concentrations.  This is shown in Figure 5 by the essentially identical molar extinction 
coefficients calculated from the amino acid sequences.   Thus their A260/A280 ratios should also be 
identical.  For truncated HBcAg this value is 0.74.  This value is similar to other proteins with 
the A280   greater than the A260.  However, for the full length HBcAg the A260/A280   value is 1.39. 
The isolated RNA gave a A260/A280 value of 1.7, which is consistent with reported values of this 
ratio for RNA.  Because HBcAg has both RNA and protein its spectrum reflects the contribution 
of both.  Because the relative contribution of each is known, this data can be used to calculate the 
fraction of each present in HBcAg.
If  one assigns  the value x for the fraction  of  HBcAg that  is  protein,  then 1-x is  the 
fraction of HBcAg that is RNA.  The absorbance at 280 nm is, therefore: εprotein at 280 nm x  +  εRNAat 
280 nm.  Likewise the absorbance at 260 nm is: εprotein at 260 nm x  +  εRNAat 260 nm. Where, in each case ε is 
the extinction coefficient.  In this case, the extinction coefficient will be expressed per milligram, 
although identical results would result from using the molar extinction coefficients.
Therefore, since the experimentally observed  A260/A280  is 1.39 the following relationship 
must exist:A260/A280   =  (εprotein at 260 nm x  +  εRNAat 260 nm )/(εprotein at 280 nm x  +  εRNAat 280 nm) For HBcAg 
the  calculated  values  of  A260  and  A280  for  a  1  mg/ml  solution  would  be  0.75  and  1.39 
respectively; for truncated HBcAg these values are 0.94 and 1.74 respectively; for RNA these 
values are 25 and 14.7 respectively.   Therefore for HBcAg the above equation yields: 1.39 = 
[0.75x  + 25 (1-x)]/([1.39x + 14.7(1-x)] and x = 78.6%   protein and 1-x = 21.4% RNA. These 
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values  are  in  good agreement  with  previously  reported  values.   This  formula  also  allows  a 
reasonable way to determine the amount of RNA remaining after treatments to remove the RNA.
Our studies confirm that HBcAg has RNA associated with it.  This was never in doubt. 
However, we have developed a simple relationship that allows quantification of the amount of 
RNA present using the absorption spectra of the proteins.  The value of about 20% RNA and 
80% protein is interesting.  If one takes the average molecular weight of a ribonucleotide as 339, 
then 1 mg of RNA would be about 3 X 10-3  mmol.  One the other hand 1 mg of HBcAg protein 
is 4.7 X 10-5 mmol.  In the nucleotide binding domain there are 16 arginine residues, so in 1 mg 
of protein there would be 7.5 X  10-4  mmol of arginine.  Each nucleotide would contribute 1 
negative charge and each arginine would contribute 1 positive charge to the HBcAg.  Therefore 
with a ratio of 1:4 for RNA:Protein, these charges would be essentially balanced.  (0.25 X 30 
compared for the RNA compared to 7.5 for the protein).  This explains why HBcAg and tHBcAg 
always migrate towards the anode during electrophoresis.
Our evidence  suggests  that  the RNA content  can  be  reduced,  though not  completely 
eliminated  upon digestion  with RNase A.  This  can  be seen when comparing  the absorption 
spectrum after digestion to wild-type core particles. A decrease in absorption at 260 nm could be 
detected which suggests that a decrease in the nucleic acid content occurred after digestion. In 
the case of the woodchuck core antigen, enough nucleic acid was removed so that it began to 
resemble its truncated counterpart with an absorption spectrum containing a maximum near 280 
nm, although it never becomes the ratio expected for just the protein. We could not, however, 
completely  remove  all  of  the  RNA.   But  rather,  as  judged  by  kinetics  studies  at  600  nm, 
reduction of the RNA content leads to aggregation. Using the digestion parameters that we set, 
the 600 nm remained with an absorbance of near zero, until however, increase in either time or 
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RNase  concentration  resulted  in  an  increase  of  absorbance  at  600 nm,  suggesting  increased 
cloudiness of the solution due to aggregated particles falling of solution. This made it impossible 
to follow the digestion by hyperchromicity (increase in A260).
Further evidence of the decrease in the RNA content can be seen when comparing the 
amount  of RNA extracted  from the core antigen particles  before and after  digestion.  Before 
digestion, 400 µg of RNA per 1 mg of HBcAg was extracted, while after digestion the amount 
extracted from the same amount of antigen was 154 µg, a 61% decrease. However, some protein 
contamination may be present in either sample as hinted by a 260/280 absorbance ratio of 1.7 
and 1.9. However,  this  decrease still  clearly indicates  that  treatment  of particles with RNase 
results in a decrease in the RNA content. This decrease in RNA content is further evidenced 
through  visualization  on  agarose  gels,  which  showed  decreased  fluorescence  upon  RNase 
digestion. Analysis of this extracted RNA through silver staining showed that the core antigens 
are most likely packaging small bacterial RNA of less than 50 bp in length. The nature of the 
packaged RNA currently remains unknown. 
Further  attempts  to  determine  the  amount  of  RNA  digested  occurred  through  the 
application of the 260/280 absorbance ratio from the absorption spectrum of the core antigens. 
Based on the absorption spectrum of tRNA, we have devised a mathematical formula (Figure 24) 
to use the 260/280 ratio of antigens to calculate the RNA and protein content. This formula was 
used to create a table listing 260/280 ratio and its corresponding RNA content (Table 3).  The 
accuracy of the formula is believed to be reasonable because the 260/280 ratio is based on sound 
physical  parameters  of  the  protein  and  the  purified  RNA.  Digestion of  the  human  particle 
resulted in a  decrease of RNA to protein content  from approximately 20-25% RNA to 13% 
RNA, an overall 48% decrease. The woodchuck antigen decreased from 21% RNA to 10% RNA 
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Figure 24:  RNA to Protein formula
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Table 3:  260/280 absorbance ratio and its resulting protein to RNA percentage
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260/280 % Protein %RNA
1.98 1.935334 98.06467
1.93 22.33651 77.66349
1.88 36.67916 63.32084
1.83 47.31316 52.68684
1.78 55.51228 44.48772
1.73 62.02689 37.97311
1.68 67.32774 32.67226
1.63 71.72515 28.27485
1.58 75.43194 24.56806
1.53 78.59897 21.40103
1.48 81.33611 18.66389
1.43 83.72535 16.27465
1.38 85.82904 14.17096
1.33 87.6955 12.3045
1.28 89.3627 10.6373
1.23 90.86094 9.13906
1.18 92.21467 7.785334
1.13 93.44382 6.556177
1.08 94.56485 5.43515
1.03 95.59141 4.408586
0.98 96.53497 3.465028
0.93 97.4052 2.5948
0.88 98.21033 1.789672
0.83 98.9574 1.042604
0.78 99.65247 0.347534
0.73 100.3008 -0.30079
0.68 100.9069 -0.90692
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and the malaria construct decreased from 17% RNA to 8% RNA, which is a 52% decrease for 
both. When analyzing the human core antigen and comparing the 48% decrease calculated from 
the 260/280 ratio and 61% decrease determined from the RNA extraction, we can approximate 
that nearly half of the RNA content could be removed.
In addition, our data provides evidence that specific nucleic acids can be reincorporated 
into hepatitis B core antigen particles during digestion with RNase A. This is strongly supported 
by the ELISA results.  The  biotin  molecule  attached  to  the  DNA used during digestion  was 
detected  with  peroxidase-labeled  streptavidin.  All  core  antigens  had  absorbance  values  well 
above two times that of the negative control, indicating a positive result. This incorporation of 
DNA can also be seen when viewing agarose gel which compared antigen that tested positive for 
biotin to digested antigen. An increase in absorbance suggests that the nucleic acid content has 
also increased. A clear increase in ethidium fluorescence can be detected between the two. When 
evaluating the absorption spectrum a slight increase at 260 nm could be seen. Additionally, the 
slight  increase in  the 260/280 ratio  supports  these findings.  It  is  also important  to  note  that 
although only a slight increase in the 260/280 ratio is found, the extinction coefficient for DNA 
differs from that of RNA. A 260/280 ratio of ~1.8 is the convention for pure DNA, while the 
ratio is ~2.0 for RNA. So even though the change in 260 seems slight it still suggests addition of 
DNA. Unlike the woodchuck and human antigens,  after  oligonucleotide addition the malaria 
construct has a 260/280 less than that of the digested particle. This may be due to fluctuation in 
the amount of RNA digested away between the two procedures. However, it is still believed that 
DNA was incorporated as supported by the ELISA assay, absorption spectrum and increase in 
ethidium bromide florescence on an agarose gel.
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Very  few  changes  in  the  structure  of  the  core  antigens  were  seen  upon  these 
manipulations. The CD spectrum remained the same throughout, indicating that the alpha helices 
remained  intact  and  unaffected.  Changes  in  the  absorption  spectrum  of  core  antigens  are 
attributed to change in the nucleic acid content. The most notable change in the structure was the 
size of the particles. In general, a trend could be seen. The particle sizes increased after digestion 
with RNase A, but remained nearly the same size as undigested particles, when digested in the 
presence of the oligonucleotide.  The decrease in nucleic acid content may give rise to steric 
interactions due to the exposure of the positively charge amino acids that originally bound the 
nucleic acids. This may cause the particle to expand in size, as exposed charges repel each other, 
resulting  in  a  larger  diameter.  With  the  oligonucleotide  present,  this  effect  may be partially 
neutralized as the DNA binds in the place of any RNA digested away, preventing the particle 
from expanding.
Our  findings,  however,  seem  to  contradict  some  of  the  findings  reported  by  other 
researchers. In one study from Kann and Gerlich et al (10), it was reported that RNase digestion 
completely degraded all packaged RNA from human core antigen. This was supported with a 
depiction of an agarose gel that contained 1µg of HBcAg per lane.  However, in none of the 
published  reports  were  spectral  data  presented,  and  the  amounts  of  HBcAg  used  were  not 
sufficient to warrant their conclusions.  Moreover, none demonstrated the production of HBcAg 
that  would migrate  other than towards the anode during electrophoresis,  and since the pI of 
HBcAg, if it only contained protein is nearly 11, their results are not consistent with removal of 
all of the RNA. Our study determined that 1µg of material produced very little fluorescence. 
After  digestion  such  a  low amount  of  particle  may  seemingly  produce  no  fluorescence.  In 
addition  commassie  blue  staining  of  the  gel  produced  no  protein  band,  raising  questions  to 
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whether or not the protein was present. A similar situation was also encountered in the study by 
Broos (2), who also used a low amount,  5µg, of HBcAg to study the RNA content  with an 
agarose gel. Again, such a low amount after digestion may seemingly produce no fluorescence. 
We hypothesize that recombinant core antigen binds RNA, both, within its capsid and its 
outer shell. It may be possible the RNase is too large of a molecule to enter the core capsid and 
digest the RNA present. Instead RNase may only be able to digest RNA presented on the outside 
of the capsid. Evidence hinting at this phenomenon is the disappearance of a fast moving band of 
RNA that is present in undigested core antigens, but not present in digested antigens (See Figure 
18). In addition the phenol-chloroform RNA extraction repeatedly reported bands of protein in 
an insoluble  pellet,  which we believe  to be denatured  protein  with RNA still  attached to  it, 
perhaps suggesting an unwillingness of the protein to release its RNA.
Of  particular  excitement  is  the  indication  that  synthetic  oligonucleotides  can  be 
incorporated  into  both  wild-type  and  modified  core  antigens.  Our  hope  is  that  the  chosen 
oligonucleotide sequence, TCC ACG TTC CTG ATG CT, with non-methylated CpGs, along 
with the presentation of the malaria epitope,  will further increase the immunogenicity of the 
malaria  construct.  This  increase  in  immunogenicity  may  be  key  to  eliciting  a  large  enough 
immune  response  in  an  organism,  in  order  to  induce  immunity.  However,  it  still  remains 
unknown how much of the oligonucleotide is bound to digested core antigens. This knowledge 
may be essential to any sequential immunological studies that may follow. The presence of the 
RNA handicaps our ability to determine this due to the different extinction coefficients of RNA 
and DNA. This makes a simple determination using 260/280 absorbance ratios unlikely. 
Future directions include being able to reduce the RNA content of the malaria construct 
to that of FDA standards for potential human usage, or removing the RNA content completely. 
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In order to accomplish this, the use of other nucleases, such as micrococcal nuclease, may be 
employed to test their effectiveness. Another goal is to try to determine the nature of the RNA, 
specifically its sequence, base pair size, and what function it may have served in E. coli. It’s of 
interest to know whether the RNA packaged by core antigens produced in bacterial systems are 
various, random, species of RNA or a specific species of RNA. This knowledge could give us 
further  insight  into  the  nature  of  nucleic  acids  core  antigens  may or  may not  preferentially 
package. 
Finally,  such  manipulations  could  be  applied  to  other  species  of  HBcAg.  Because  a 
percentage of the population, vaccinated against or exposed to HBV, may still contain titers of 
anti-HBcAg, it usage may not be best suited as a platform for an adjuvant or vaccine carrier for 
humans. For this reason the malaria epitope was inserted into the woodchuck core antigen, rather 
than the human core antigen. Just like the woodchuck core antigen, the duck, ground squirrel, or 
wooly monkey core antigens could be great adjuvant candidates. It’s possible that any one of 
these core antigens may be able to tolerate larger or more complex epitope insertions and elicit 
just as great or greater immune response in humans. Currently, we hope to begin immunological 
studies  involving the malaria  construct  with the added oligonucleotide  in order to access  its 
present effectiveness. 
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